Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 80 (RPL21P80)

Target
RPL21P80
Molecular classification
Other (pseudogene)
01

Overview

Ribosomal protein L21 pseudogene 80 (RPL21P80) is a processed pseudogene—a DNA segment with high sequence similarity to the ribosomal protein L21 gene (RPL21)—but does not code for a functional protein product[2]. Pseudogenes arise from duplication or retrotransposition events and are generally non-functional, lacking the regulatory elements or sequences necessary for protein expression. There is no evidence that RPL21P80 is transcribed or translated, nor is it associated with therapeutic targeting or disease relevance. The functional gene RPL21 encodes a protein component of the ribosomal large 60S subunit with roles in protein synthesis and, in some contexts, cell growth and disease, but this does not extend to its pseudogenes[1][3][5][2]. "Ribosomal protein L21 pseudogene 80" is not a drug target and has no established biological role, disease association, or pharmacological relevance. If focused on a protein-coding gene with therapeutic or biological significance, refer to the *RPL21* gene/protein, not its pseudogene[2].

Other names
RPL21_32_892RPL21P80

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 80 (RPL21P80).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 80 (RPL21P80).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call